VEGFD (Vascular Endothelial Growth Factor D)

News alerts, weekly reports and conference planners

Entrez ID:

VEGFD elevation	Colorectal Cancer	VEGFD elevation	Colorectal Cancer	ramucirumab Sensitive: B - Late Trials ramucirumab Sensitive : B	ramucirumab Sensitive: B - Late Trials ramucirumab Sensitive : B
VEGFD-L	Colorectal Cancer	VEGFD-L	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
VEGFD elevation	Non Small Cell Lung Cancer	VEGFD elevation	Non Small Cell Lung Cancer	ramucirumab Resistant: C3 – Early Trials ramucirumab Resistant : C3	ramucirumab Resistant: C3 – Early Trials ramucirumab Resistant : C3
VEGFA elevation + VEGFD-L	Non Small Cell Lung Cancer	VEGFA elevation + VEGFD-L	Non Small Cell Lung Cancer	ramucirumab Sensitive: C3 – Early Trials ramucirumab Sensitive : C3	ramucirumab Sensitive: C3 – Early Trials ramucirumab Sensitive : C3
VEGFD overexpression	Renal Cell Carcinoma	VEGFD overexpression	Renal Cell Carcinoma	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D

Associations(5)